Clinical Trials Logo

Loss-of-control Eating clinical trials

View clinical trials related to Loss-of-control Eating.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05592119 Recruiting - Clinical trials for Attention Deficit/Hyperactivity Disorder

Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder

Start date: January 11, 2023
Phase:
Study type: Observational

Loss of control eating (LOC-E) in youth predicts the later development of full syndrome eating disorders, such as binge-eating disorder (BED), and therefore, could be a relevant target for prevention interventions. Children with attention deficit/hyperactivity disorder (ADHD) are at higher risk of experiencing LOC-E than healthy controls, and there is evidence that related neurocognitive predisposing factors, such as impulsivity and dysfunctional reward processing, are associated with the pathogenesis of LOC-E. Therefore, it is pertinent to examine whether modifying these neurocognitive symptoms influences LOC-E and the subsequent development of eating disorders. Stimulants are an efficacious treatment for impulsivity in youth with ADHD and have been shown to improve symptoms of binge eating in adults; however, studies have not prospectively explored the effect of stimulants on LOC-E in youth. To explore this gap, the investigators aim to collect prospective observational data in a clinical setting to measure change in LOC-E episodes and secondary outcomes in youth aged 8 to 13 years old with ADHD and LOC-E who are treated with stimulants. The investigators will collect outcome measures prior to stimulant initiation (baseline) and 3 months after stimulant initiation.

NCT ID: NCT04599478 Recruiting - Obesity/Overweight Clinical Trials

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Start date: June 29, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexone/bupropion medication.

NCT ID: NCT03868670 Recruiting - Obesity, Morbid Clinical Trials

Responsive Neurostimulation For Loss Of Control Eating

DBSLOC
Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.